Search

everythinglearnresearchcommunity

for

Search:↓

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Researchers found genetic mutations causing hypohidrotic ectodermal dysplasia in 88% of studied patients and identified new mutations and genetic variations affecting the disease.

Finasteride affects prostate weights and pituitary activity differently with age.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

Found different proteins in balding and non-balding cells, giving insight into hair loss causes.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

This text talks about how to treat hair loss in women. It suggests different options and stresses the importance of support.

The conclusion is that certain genetic factors and blood types may affect COVID-19 severity, but changes in ACE2 and TMPRSS2 genes are not clearly linked to it.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

PSA could be a marker for hyperandrogenism in women, but more research is needed.

New compounds may help treat prostate cancer by reducing cell growth.

The document concludes that alopecia has various forms, each with specific treatments, but no definitive cure for certain types like CCCA has been proven.

The document likely offers guidance on treating a woman's excessive hair growth, considering her symptoms and obesity.

Lower doses of treatments for hirsutism and acne in PCOS are effective and cause fewer side effects.

Finasteride exposure in pregnancy causes genital abnormalities in male rats.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

The protein StAR is found in 17 different organs and can affect hair loss and brain functions, but its full role is not yet fully understood.

An extract from Quercus acutissima bark was found to reduce sebum production and block an enzyme linked to acne.

Future research on ectodysplasin should explore its role in diseases, stem cells, and evolution, and continue developing treatments for genetic disorders like hypohidrotic ectodermal dysplasia.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Finasteride inhibits enzyme activity in rhesus macaques, suggesting they're useful for evaluating similar drugs.

Topical cetirizine improves hair density and thickness in androgenetic alopecia, but more research is needed.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.